Physician

Adam Lee Alpers, D.O.

According to 2025 Medicare claims, Adam Alpers, D.O. (NPI: 1184629321) practices family practice in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is OCALA FAMILY MEDICAL CENTER, INC. (NPI: 1871589192; TIN: 593158481) and primary practice location at 34471-1391. Alpers is affiliated with the Pathways Accountable Care, LLC d/b/a Pathways Health Partners (ACO ID: D0048), participating under the REACH model.

Alpers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,197 traditional Medicare patients, billed 15,069 HCPCS/CPT codes, and received $179,697 in Medicare payments. The top billing code was 80061 (Blood test, lipids (cholesterol and triglycerides)). Part D data shows 485 prescription claims across 235 beneficiaries totaling $23,250 in drug costs, led by Atorvastatin Calcium (Atorvastatin Calcium). 2023 DME data shows 335 claims. Open Payments data shows 7 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $395,867 to $23,250. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,036 to $1,960.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	818	15,993	$324,002
2016	819	16,625	$308,774
2017	855	16,858	$306,928
2018	976	19,081	$332,264
2019	1,166	18,840	$319,311
2020	1,469	21,357	$316,822
2021	1,549	23,494	$369,783
2022	1,421	21,451	$346,735
2023	1,453	16,380	$237,756
2024	1,197	15,069	$179,697

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	643	7,885	$395,867
2016	611	7,439	$375,686
2017	668	7,330	$420,502
2018	686	6,911	$372,591
2019	673	6,243	$290,898
2020	691	5,712	$276,255
2021	687	6,153	$320,802
2022	730	6,620	$401,101
2023	568	1,789	$105,555
2024	235	485	$23,250

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	112	464	$13,242
2016	97	368	$9,611
2017	50	232	$5,966
2018	56	194	$3,708
2019	28	117	$1,719
2020	25	130	$3,158
2021	17	91	$2,667
2022	N/R	118	$4,068
2023	317	335	$1,459,057
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80061	Blood test, lipids (cholesterol and triglycerides)	786	1,095	$13
80053	Blood test, comprehensive group of blood chemicals	812	1,149	$10
36415	Insertion of needle into vein for collection of blood sample	859	1,292	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	811	1,144	$8
81002	Urinalysis, manual test	753	1,039	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Atorvastatin Calcium	Atorvastatin Calcium	29	2,528	$238
Levothyroxine Sodium	Levothyroxine Sodium	33	2,130	$227
Lisinopril	Lisinopril	22	2,010	$168
Gabapentin	Gabapentin	14	830	$166
Rosuvastatin Calcium	Rosuvastatin Calcium	13	1,200	$148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$126	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Lee Alpers, D.O.?

Tedicare shows public-source Medicare data for Adam Lee Alpers, D.O. (NPI 1184629321), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Lee Alpers, D.O. have ACO affiliation data?

Adam Lee Alpers, D.O. is shown with ACO affiliation data for Pathways Accountable Care, LLC d/b/a Pathways Health Partners (REACH, ACO ID D0048).

What billing organization is linked to Adam Lee Alpers, D.O.?

Adam Lee Alpers, D.O. is linked to OCALA FAMILY MEDICAL CENTER, INC. (billing NPI 1871589192) in the available physician profile data.

Does Adam Lee Alpers, D.O. have Open Payments data?

Adam Lee Alpers, D.O. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.